FR2073279A1 - Yoghurt -contg antibiotic and sulphonamide resistant lactobacilli - for therapeutic and dietetic use - Google Patents

Yoghurt -contg antibiotic and sulphonamide resistant lactobacilli - for therapeutic and dietetic use

Info

Publication number
FR2073279A1
FR2073279A1 FR6943728A FR6943728A FR2073279A1 FR 2073279 A1 FR2073279 A1 FR 2073279A1 FR 6943728 A FR6943728 A FR 6943728A FR 6943728 A FR6943728 A FR 6943728A FR 2073279 A1 FR2073279 A1 FR 2073279A1
Authority
FR
France
Prior art keywords
contg
antibiotic
therapeutic
sulphonamide
yoghurt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6943728A
Other languages
French (fr)
Other versions
FR2073279B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Priority to FR6943728A priority Critical patent/FR2073279A1/en
Publication of FR2073279A1 publication Critical patent/FR2073279A1/en
Application granted granted Critical
Publication of FR2073279B1 publication Critical patent/FR2073279B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1232—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Yoghourt for therapeutic or dietetic use contg. lactobacilli from at least one strain of organism resistant to antibiotics and sulphonamides. Useful for restoring the intestinal microbial flora which may have been deranged by antibiotic or sulphohamide therapy. Normal digestion of food in the intestine is promoted. Prefd. resistant strains are from the species Lactobacillus bulgaricus, L. jugurti, L. helveticus, L. lactis, L. casei, L. acidophilus, L. plantarum and L. leichmanii. Non-resistant strains of lactobacillus and Streptococcus lactis or S. thermophilus may be added.
FR6943728A 1969-12-17 1969-12-17 Yoghurt -contg antibiotic and sulphonamide resistant lactobacilli - for therapeutic and dietetic use Granted FR2073279A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR6943728A FR2073279A1 (en) 1969-12-17 1969-12-17 Yoghurt -contg antibiotic and sulphonamide resistant lactobacilli - for therapeutic and dietetic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6943728A FR2073279A1 (en) 1969-12-17 1969-12-17 Yoghurt -contg antibiotic and sulphonamide resistant lactobacilli - for therapeutic and dietetic use

Publications (2)

Publication Number Publication Date
FR2073279A1 true FR2073279A1 (en) 1971-10-01
FR2073279B1 FR2073279B1 (en) 1973-01-12

Family

ID=9044734

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6943728A Granted FR2073279A1 (en) 1969-12-17 1969-12-17 Yoghurt -contg antibiotic and sulphonamide resistant lactobacilli - for therapeutic and dietetic use

Country Status (1)

Country Link
FR (1) FR2073279A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2161766A1 (en) * 1971-11-15 1973-07-13 Marchand & Vasseneix
EP0165726A2 (en) * 1984-06-19 1985-12-27 Kabushiki Kaisya Advance Intestinal microflora-improving agent
EP0538646A1 (en) * 1991-10-25 1993-04-28 Societe Des Produits Nestle S.A. Process for preparing an acidified milk
FR2728912A1 (en) * 1995-01-02 1996-07-05 Gervais Danone Co Lactic ferment for use in prepn. of fermented dairy prods.
WO1996020607A1 (en) * 1995-01-02 1996-07-11 Compagnie Gervais Danone Milk starter culture and use thereof for preparing antidiarrhoeal products
FR2739869A1 (en) * 1995-10-13 1997-04-18 Gervais Danone Co Starter culture for fermented milk produce with anti-diarrhoea activity

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2161766A1 (en) * 1971-11-15 1973-07-13 Marchand & Vasseneix
EP0165726A2 (en) * 1984-06-19 1985-12-27 Kabushiki Kaisya Advance Intestinal microflora-improving agent
EP0165726A3 (en) * 1984-06-19 1988-01-13 Kabushiki Kaisya Advance Intestinal microflora-improving agent
EP0538646A1 (en) * 1991-10-25 1993-04-28 Societe Des Produits Nestle S.A. Process for preparing an acidified milk
CH683223A5 (en) * 1991-10-25 1994-02-15 Nestle Sa A process for preparing an acidified milk.
US5972393A (en) * 1991-10-25 1999-10-26 Nectec S.A. Preparation of dehydration acidified milk product
US6156353A (en) * 1991-10-25 2000-12-05 Nestec S. A. Strains of lactobacillus helveticus for forming exclusively L(+) lactic acid in milk
FR2728912A1 (en) * 1995-01-02 1996-07-05 Gervais Danone Co Lactic ferment for use in prepn. of fermented dairy prods.
WO1996020607A1 (en) * 1995-01-02 1996-07-11 Compagnie Gervais Danone Milk starter culture and use thereof for preparing antidiarrhoeal products
FR2739869A1 (en) * 1995-10-13 1997-04-18 Gervais Danone Co Starter culture for fermented milk produce with anti-diarrhoea activity

Also Published As

Publication number Publication date
FR2073279B1 (en) 1973-01-12

Similar Documents

Publication Publication Date Title
Saxelin et al. Lactobacilli and bacteremia in southern Finland, 1989–1992
Elo et al. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco‐2: comparison with other dairy strains
Goldin Health benefits of probiotics
Salminen et al. Development of selection criteria for probiotic strains to assess their potential in functional foods: a Nordic and European approach
Meurman et al. Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium
DE69219768D1 (en) Milk bacteria
CA3075235A1 (en) New use for treatment of clostridium difficile infections
Tomičić et al. Beneficial properties of probiotic yeast Saccharomyces boulardii
GB2338245A (en) Immunity enhancing lactic acid bacteria
EA200101262A1 (en) DIETARY OR PHARMACEUTICAL COMPOSITION FOR APPLICATION FOR PREVENTION OR TREATMENT OF HYPEROXALURIA
GB930107A (en) Therapeutic oral preparation of micro-organisms
PT1251860E (en) SOMNOGENIC ACTIVITY OF NON-PATHOGENIC BACTERIA OF LACTIC ACID
FR2073279A1 (en) Yoghurt -contg antibiotic and sulphonamide resistant lactobacilli - for therapeutic and dietetic use
Vemuri et al. Probiotics: a novel approach in improving the values of human life
RU2013126604A (en) NON-REPLICATING PROBIOTIC BACTERIA AND PREVENTION OR THERAPY OF INFECTIONS IN ORDER TO REDUCE THE MISSION OF VISITS OF SCHOOL OR INSTITUTIONS OF DAY CARE FOR CHILDREN
FR2330334A1 (en) Food prods. e.g. yoghurt contg. human or animal intestinal flora - prepd. by adding a suitable bacterial ferment during prodn.
张秋香 et al. Fructooligosaccharides and xylooligosaccharides utilization properties of lactic acid bacteria
GB2228494A (en) Method of obtaining a bacterial ferment for medical-dietetic product
Solomon New aspects of the production of fergated dairy products with probiotic properties
CN111011514A (en) Synbiotics milk powder
Fatima Probiotics as living drugs to resolve urinary tract infections
UA54411U (en) method for treatment of patients with chronical generalized periodontitis
Mohammadabadi et al. Lactic Acid Bacteria of Camel Milk for Health Promotion
Dutta et al. A review on probiotics
Singh et al. Probiotics–An emerging concept

Legal Events

Date Code Title Description
ST Notification of lapse